Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Integra LifeSciences to Present at Healthcare Conferences in September 2018


Posted on: 15 Aug 18

PLAINSBORO, N.J., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conferences in September:

  • On Thursday, September 6, 2018 at 8:35 a.m. ET, Glenn Coleman, chief financial officer will present at the Wells Fargo 2018 Healthcare Conference in Boston, MA. The session will be available through live audio webcast and can be accessed from the Investor section of www.integralife.com
     
  • On Thursday, September 13, 2018 at 2:05 p.m. ET, Peter Arduini, president and chief executive officer, will present at the Morgan Stanley 16th Annual Healthcare Conference in New York, NY. The session will be available through live audio webcast and can be accessed from the Investor section of www.integralife.com.

About Integra LifeSciences
Integra LifeSciences is a global leader in regenerative technologies, neurosurgical and extremity orthopedic solutions dedicated to limiting uncertainty for clinicians, so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®, Cadence®, CertasTM, Codman®, CUSA®, DuraGen®, DuraSeal®, ICP Express®, Integra®, MediHoney®, MicroFrance®, PriMatrix®, Salto Talaris®, SurgiMend®, TCC-EZ®, Titan™ and VersaTru™.  For the latest news and information about Integra and its brands, please visit www.integralife.com.

Statements made at the upcoming conferences may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item 1A of Integra's Annual Report on Form 10-K for the year ended December 31, 2017 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results. These forward-looking statements are made only as the date thereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contacts: 
Sravan Emany 
Vice President, Treasury & Investor Relations 
(609) 936-2488 
sravan.emany@integralife.com 
  
Michael Beaulieu 
Director, Investor Relations 
(609) 750-2827 
michael.beaulieu@integralife.com
  
Media Contact: 
Laurene Isip 
Senior Director, Global Corporate Communications 
(609) 750-7984 
laurene.isip@integralife.com 

GlobeNewswire
globenewswire.com

Last updated on: 16/08/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.